Risk factors associated with 30-day hospital readmissions among persons living with HIV in Nantong, China.


Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
06 2023
Historique:
medline: 2 6 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

To estimate 30-day hospital readmission rates among persons living with HIV (PLWH) at the Nantong Infectious Disease Hospital in China and analyse the related risk factors. A single-centre retrospective cohort study was conducted. There were 894 PLWH records obtained from the electronic medical record (EMR) system at the Nantong Infectious Disease Hospital in China, from October 2013 to February 2018. The 30-day readmission rates were calculated, and the risk factors were analysed by generalised estimating equations (GEEs). A total of 1153 hospitalizations from 894 patients were recorded between October 2013 and February 2018. The median time of 30-day readmissions was 13 days (interquartile range (IQR), 6-23). The reasons for all causes, acquired immunodeficiency syndrome (AIDS)-defining illnesses (ADIs), and non-AIDS-defining infections (non-ADIs) were 9.08, 13.52, and 7.91%, respectively. The results from the GEE analysis demonstrated that the risk factors associated with 30-days readmissions were as follows: no antiretroviral therapy (ART) prior to hospitalisations (odds ratio (OR) = 1.90, 95% confidence interval (CI): 1.21-3.00), low CD4 counts (OR = 2.17, 95% CI: 1.33-3.54), and multiple comorbidities (OR = 6.45, 95% CI: 1.62-25.73). Early detection of HIV infection and early initiation of ART treatment are the keys to controlling 30-day readmissions.

Identifiants

pubmed: 36935424
doi: 10.1177/09564624231160448
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-475

Auteurs

Wei Wang (W)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.
Department of GCP Research Center, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, China.

Hao Huang (H)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Yuxin Cao (Y)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Xiaoyang Duan (X)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Min Li (M)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Gang Qin (G)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Meiyin Zou (M)

Department of Infectious Diseases, Affiliated Nantong Hospital 3 of Nantong University, China.

Xun Zhuang (X)

Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH